Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Metsä Spring hires textile fibre industry expert Kishore Shouche to strengthen the Kuura development team

Kishore Shouche has extensive industry experience from both pilot and commercial textile fibre production, adding critical technical insights to Metsä Spring’s Kuura textile fibre demo plant in Äänekoski, Finland.Espoo, Finland (November 1st, 2023) Metsä Group’s innovation company, Metsä Spring , is supporting the Kuura textile fibre project at the demo plant in Äänekoski by hiring a new Technology Manager, Kishore Shouche. The project aims to build a new, sustainable, and commercially viable Nordic wood textile fibre business for Metsä Group. Kishore’s nearly three

A 5-year journey – UPM Raflatac announces further progress towards the Ellen MacArthur Foundation’s New Plastics Economy Global Commitment

(UPM Raflatac, Helsinki, 1 November 2023 at 11:00 EET) – UPM Raflatac has made further progress toward a more circular economy for plastics and a future beyond fossils in 2022. The progress towards 2025 commitments is detailed in the New Plastics Economy Global Commitment 2023 Progress Report  by the Ellen MacArthur Foundation  and the UN Environment Programme ( UNEP). The report provides transparency on how major businesses are addressing the plastic

LED iBond launches new high-power toplighting lamp for the large international greenhouse market. Patent application filed

Inside information Company announcement no. 80LED iBond has developed a new toplighting lamp (marketed as HORTISABER[TM]) with a unique design targeted the established market for toplighting lamps used in modern greenhouse facilities around the world.  The lamp is specifically designed for the indoor farming industry producing both crops and various type of plants, and has a power of 1000W, a length of 6 meters, and a very competitive performance especially in terms of energy efficiency, light homogeneity, spectral compositions, thermal properties, as well as low installation cost due

Research study abstract by Nightingale Health on heart disease prevention wins American Heart Association’s Paul Dudley White International Scholar Award

Press release, 1 November 2023 at 10:45 a.m. (EET)  A research study abstract submitted by experts from Nightingale Health has won the American Heart Association’s Paul Dudley White International Scholar Award. The award is given to the highest ranked research study abstract submitted from each country to the American Heart Association’s Scientific Sessions 2023. The award is named after Dr. Paul Dudley White, who was a founder of the American Heart Association and an early leader in preventative cardiology.  The study “Metabolomic Biomarker Profiling Improves Cardiovascular Risk

Change in the number of shares and votes in Starbreeze AB

In accordance with Starbreeze’ articles of association, holders of series A-shares have the right to request that the shares be converted into series B-shares. The purpose of the conversion program is eventually to only have series B-shares issued. Such a conversion reduces the total number of votes in the company but does not affect owner’s share in terms of capital. When such conversion has taken place, the company has an obligation according to law to publish information about any changes on a monthly basis.During the current month, at the request of shareholder’s, 41,000 shares of

Cereno Scientific releases Insights video season 2 episode 5 with Phil B. Adamson, Abbott

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that episode 5 of season 2 in the Insights Video Series has been released. The video highlights the cutting-edge technology CardioMEMS HR System, used in the Phase II study of CS1 through a collaboration agreement with Abbott, and its future potential in personalized medicine for the rare disease pulmonary arterial hypertension (PAH). Participating in the video is Phil B. Adamson, MD, MSc Divisional Vice President and Chief Medical Officer of

Calmark presentation at investors meeting at Financial Stockholm

Calmark Sweden AB's ("Calmark" or "the Company") Chairman of the board Mathias Karlsson has presented at Financial Stockholm. The presentation is available via link below. The subscription period in the Company’s rights issue of units runs until the 10[th] of November 2023.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE

Observe Medical ASA – Key information relating to the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. OTHER RESTRICTIONS ARE APPLICABLE. Observe Medical ASA – Key information relating to the rights issue Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") earlier today, on 1

Metsä Group and Valmet to develop a joint sustainability model for industrial investment projects

Metsä Group and Valmet are jointly developing a comprehensive operating model to ensure sustainability in technology and maintenance investments. The model will address various aspects of sustainability related to the environment, social responsibility and governance (ESG). It will be used to verify the sustainability of the process technology projects delivered by Valmet to Metsä Group and the related supply chains. Metsä Group and Valmet have set up a joint working group to develop and deploy the sustainability model. The goal is to adopt the model by 2027. “As part of its strategic

NIB’s third quarter results: Strong earnings and focus on green transition

During the first nine months of 2023, the Nordic Investment Bank (NIB) delivered net profits of EUR 195 million (EUR 84 million in the same period in 2022) and disbursed EUR 2,050 million (EUR 2,883 million).During the quarter, new loans were signed to finance marine decarbonisation and new renewable energy capacity and to strengthen the electricity distribution networks in the region, for example.NIB continued to prioritise high impact projects. During the first nine months of 2023, projects achieving a “good” or “excellent” mandate rating accounted for 99.8% of the total amount of

Valmet and Metsä Group to develop a joint sustainability model for industrial investment projects

Valmet Oyj’s press release on November 1, 2023 at 10:00 a.m. EETValmet and Metsä Group are jointly developing a comprehensive operating model to ensure sustainability in technology and maintenance investments. The model will address various aspects of sustainability related to the environment, social responsibility and governance (ESG). It will be used to verify the sustainability of the process technology projects delivered by Valmet to Metsä Group and the related supply chains. Valmet and Metsä Group have set up a joint working group to develop and deploy the sustainability model. The

Over one hundred theme cruises next year – special departures with both the latest trends and nostalgic vibes draw travellers

For Finns, the destination or the travel programme is more and more often the reason they take a cruise. A record number of special cruises are being arranged next year – more than one hundred in all. The themes vary from champagne to stand-up comedy and from different musical genres to fashion. Today, there is an especially strong desire for relaxation and down-to-earth themes such as handicrafts and gardening.When tickets went on sale for the Kaija Koo special cruise on Viking Grace sailing next May, all 2,000 tickets sold out in two hours. Things are selling almost as quickly if

AegirBio AB Receives $239,547 award from the National Institutes of Health RADx Tech Program

As previously announced, AegirBio AB, a leading innovator in saliva-based diagnostics solutions, has received a phase 1 award from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program for an accessibility project for multiplex testing.Today, AegirBio has received funds of $239,547. This award, totaling up to $1.2 million, enables AegirBio AB to commence work towards their continued pursuit of advancements in the field of at-home self-testing. "We are honored to have received the first installment of the RADx Tech award," said Marco Witteveen, CEO

Carbiotix reports promising results from CarbiAXOS metformin study

Carbiotix (publ) ("Carbiotix" or the "Company") announces today promising preliminary results from the 4-month randomised controlled CarbiAXOS intervention study involving type-2 diabetes patients on metformin. The preliminary results reveal that 20% of patients in the intervention cohort responded positively to a prebiotic containing CarbiAXOS, experiencing an average improvement of 15% in HbA1c (blood glucose) levels and an upregulation of Short Chain Fatty Acid (SCFA) levels. These results are in line with our ambition, which was to replicate and substantiate the results from the 2018/2019

Observe Medical ASA: Proposed rights issue and notice of extraordinary general meeting in connection with the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Observe Medical ASA: Proposed rights issue and notice of extraordinary general meeting in connection with the rights issue

AegirBio focuses on RadX project, will not uphold CE-markings for the MagniaReader TDM tests

AegirBio, a leading innovator in saliva-based diagnostics solutions, today announces that it will focus towards pioneering advancements in Therapeutic Drug Monitoring (TDM) through the development of a groundbreaking platform under the RadX initiative, coupled with a robust business development strategy.In line with this decision, AegirBio will continue to offer its current MagniaReader and the two TDM tests for the MagniaReader, albeit exclusively for research purposes and will thus not uphold the CE markings for the said PoC tests for infliximab (Remicade) and natalizumab (Tysabri). These

MTG increases ownership in PlaySimple to 100%

Modern Times Group MTG AB (publ) (“MTG”) today announced that it now owns 100% of its Indian casual gaming studios PlaySimple, in line with the timeline to full ownership announced at the time of the acquisition in 2021. At this stage MTG has not been able to transfer Class B shares (currently held by MTG as Class C shares ) to the founders of PlaySimple as per the original purchase agreement. MTG continues to strongly believe in the long-term benefits of having PlaySimple’s founders hold shares in the group, and intends to continue exploring options to achieve this.In order to explore

Invitation to presentation of BioArctic’s third quarter report for July - September 2023 on November 8 at 9.30 a.m. CET

Stockholm, Sweden, November 1, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B)will publish the company’s third quarter report for July – September 2023 onWednesday, November 8, 2023, at 08:00 a.m. CET.In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on November 8, at 09:30 CET, where Gunilla Osswald, CEO, and Anders Martin-Löf, CFO, will present BioArctic and comment on the third quarter report for July – September 2023, followed by a Q&A-session. If you wish to participate via webcast, please use

The subscription price for the warrants of series TO3 in PEPTONIC medical AB has been determined to SEK 0.05 and the exercise period starts November 2, 2023

PEPTONIC medical AB ("Peptonic" or "the Company") completed a rights issue of units on Spotlight Stock Market in January 2023. Each warrant of series TO3 entitles to subscribe for one (1) new share in the Company. The exercise price for the warrants of series TO3 have been determined to 70 percent of the volume-weighted average price in the Company’s share on Spotlight Stock Market during the measurement period, which ran from and including October 18, 2023, up to and including October 31, 2023, however not higher than SEK 0.12 and not less than the quota value of the Company’s shares. During

YIT Corporation’s financial reporting and Annual General Meeting in 2024

YIT Corporation Stock Exchange Release 1 November 2023 at 09:30 a.m.YIT Corporation’s financial reporting and Annual General Meeting in 2024 YIT will publish the Financial Statements Bulletin for 2023 on Friday, 9 February 2024. Financial Statements 2023 will be published during week 8/2024 at the latest. In addition, YIT will publish two interim reports and a half-year report in 2024: · Interim Report for January-March on Tuesday, 30 April 2024 · Half-year Report for January-June on Friday, 26 July 2024 · Interim Report for January-September on Thursday, 31 October 2024

Metso's financial reporting and Annual General Meeting in 2024

Metso Corporation’s stock exchange release on November 1, 2023, at 9:30 a.m. EETMetso Corporation will publish its financial reports in 2024 as follows: · Financial Statements Review for 2023 on February 16, 2024 · Annual Report for 2023 during the week of March 18, 2024 · Interim Report for January - March 2024 on April 25, 2024 · Half-Year Financial Report for January - June 2024 on July 24, 2024 · Interim Report for January – September 2024 on October 24, 2024 The Annual General Meeting is planned to be held on April 25, 2024. Metso’s Board of Directors will summon

Archer Limited: Invitation to Third Quarter 2023 Earnings Release Call

Hamilton, Bermuda (November 1[st], 2023) Archer Limited’s third quarter 2023 results are scheduled to be released on November 3[rd], 2023, before the start of trading on Oslo Stock Exchange.  In connection with the earnings release, a presentation will be held at 09:00 am CET on November 3[rd], 2023. To follow the presentation, the following options are available: A. Webcast To register for the webcast please go to https://events.q4inc.com/attendee/991788945 B. Conference call To access the call, which is open to the public, please dial in at the participant telephone

BioStock: New CMO strengthens Lipum ahead of continued clinical development

Lipum is in the final stages of the clinical phase I study with SOL-116. In parallel, the company is preparing for the next step, a phase II study in rheumatoid arthritis. To strengthen its team for this, the company has recently recruited Karin Franck-Larsson as CMO. BioStock had the opportunity to interview Karin about her background and her expectations for her new role.Read the full article at biostock.se: https://www.biostock.se/en/2023/11/new-cmo-strengthens-lipum-ahead-of-continued-clinical-development/ This is a press release from BioStock - Connecting Innovation & Capital.

Photocure ASA: Invitation to presentation of third quarter 2023 financial results

Oslo, Norway, 1 November 2023: Photocure ASA (Photocure, PHO: OSE) will announce the third quarter 2023 financial results on Wednesday 8 November 2023 at 08:00 CET and will present a live webcast at 14:00 CET the same day.The quarterly report and presentation will be published at 08:00 CET and will be publicly available at www.photocure.com. The investor presentation will be streamed live and be hosted by Dan Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45

There are no items matching the current filter
There are no more items matching the current filter
Back to top